These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease. Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151 [TBL] [Abstract][Full Text] [Related]
3. Ceftriaxone-induced hemolytic anemia in a child successfully managed with intravenous immunoglobulin. Vehapoğlu A; Göknar N; Tuna R; Çakır FB Turk J Pediatr; 2016; 58(2):216-219. PubMed ID: 27976566 [TBL] [Abstract][Full Text] [Related]
4. Severe hemolytic crisis after ceftriaxone administration. Goyal M; Donoghue A; Schwab S; Hasbrouck N; Khojasteh S; Osterhoudt K Pediatr Emerg Care; 2011 Apr; 27(4):322-3. PubMed ID: 21467885 [TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone-induced hemolytic anemia: case report and review of literature. Northrop MS; Agarwal HS J Pediatr Hematol Oncol; 2015 Jan; 37(1):e63-6. PubMed ID: 24878619 [TBL] [Abstract][Full Text] [Related]
6. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature. Leicht HB; Weinig E; Mayer B; Viebahn J; Geier A; Rau M BMC Pharmacol Toxicol; 2018 Oct; 19(1):67. PubMed ID: 30359322 [TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone-induced hemolysis in a child with Lyme arthritis: a case for antimicrobial stewardship. Boggs SR; Cunnion KM; Raafat RH Pediatrics; 2011 Nov; 128(5):e1289-92. PubMed ID: 21969285 [TBL] [Abstract][Full Text] [Related]
8. Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report. Kumar S; Bansal R; Bansal P; Dhamija RK; Neurology D Perm J; 2020; 24():. PubMed ID: 31905339 [TBL] [Abstract][Full Text] [Related]
9. Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease. Bell MJ; Stockwell DC; Luban NL; Shirey RS; Shaak L; Ness PM; Wong EC Pediatr Crit Care Med; 2005 May; 6(3):363-6. PubMed ID: 15857541 [TBL] [Abstract][Full Text] [Related]
10. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies. Dinesh D; Dugan N; Carter J Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898 [TBL] [Abstract][Full Text] [Related]
11. Ceftriaxone-Induced Hemolytic Anemia in a Jehovah's Witness. Tasch J; Gonzalez-Zayaz P Am J Case Rep; 2017 Apr; 18():431-435. PubMed ID: 28428532 [TBL] [Abstract][Full Text] [Related]
12. Unusual serological findings associated with ceftriaxone-induced immune hemolytic anemia in a child with disseminated low-grade glioma. Pecker LH; Timsar A; Pary PP; Denomme GA; Criss VR; Luban NL; Hwang EI; Wong EC Pediatr Blood Cancer; 2016 Oct; 63(10):1852-5. PubMed ID: 27304608 [TBL] [Abstract][Full Text] [Related]
13. Multiple Drugs Causing Severe Anemia in Infective Endocarditis. Singh A; Shetty PN; Singh BM; Devasia T Cardiovasc Hematol Disord Drug Targets; 2016; 16(1):3-5. PubMed ID: 27215287 [TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone-induced immune hemolytic anemia. Neuman G; Boodhan S; Wurman I; Koren G; Bitnun A; Kirby-Allen M; Ito S Ann Pharmacother; 2014 Dec; 48(12):1594-604. PubMed ID: 25163809 [TBL] [Abstract][Full Text] [Related]
15. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia. Arndt PA; Leger RM; Garratty G Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048 [TBL] [Abstract][Full Text] [Related]
16. Hemolysis from ceftriaxone. Med Lett Drugs Ther; 2002 Nov; 44(1144):100-1. PubMed ID: 12451362 [No Abstract] [Full Text] [Related]
18. Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of 'chronic Lyme disease'. De Wilde M; Speeckaert M; Callens R; Van Biesen W Acta Clin Belg; 2017 Apr; 72(2):133-137. PubMed ID: 27169474 [TBL] [Abstract][Full Text] [Related]